Philadelphia-based Biotech Company AUM LifeTech Awarded $400,000 NCI/NIH Grant to Advance Their Lung Cancer Immunotherapy Program Using RNA-Targeting Gene Therapy with Checkpoint Inhibitors

/PRNewswire/ -- AUM LifeTech, Inc., a Philadelphia-based preclinical stage biotechnology company, has received a Small Business Innovation Research (SBIR)...

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,University City ,India ,Philadelphia ,American ,Veenu Aishwarya ,Michelle Ottey ,Alan Gewirtz ,Anne Nadol ,Dwayne Hancock ,Claire Greenwood ,Mitch Stoller ,Steven Albelda ,University City Science Center Port Business Incubator ,Linkedin ,National Cancer Institute ,Translational Center ,Small Business Innovation Research ,Perelman School Of Medicine ,Abramson Cancer Center ,Lifetech Inc ,Laboratory Medicine ,Hospital Of The University Pennsylvania ,University Of Pennsylvania School Medicine ,National Institutes Of Health ,Division Of Transplantation Immunology ,American Association For Cancer Research ,City Department Of Commerce ,National Institutes ,Chief Executive Officer ,Transplantation Immunology ,Perelman School ,Lung Cancer ,Vice Chief ,Critical Care Division ,American Association ,Cancer Research ,Vice President ,Commerce Director ,Greater Philadelphia ,Senior Vice President ,Economic Competitiveness ,University City Science Center ,Port Business Incubator ,Innovation Campus ,Managing Director ,Pennsylvania School ,Aum Lifetech ,Nc ,Health Care Amp Hospitals ,Biotechnology ,Medical Pharmaceuticals ,Pharmaceuticals ,Awards ,Clinical Trials Amp Medical Discoveries ,